Name: MoonLake Immunotherapeutics (MLTX) Balance Sheet
Creator: FinSpry

MoonLake Immunotherapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for MoonLake Immunotherapeutics (MLTX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Current Assets
Cash and Cash Equivalents	180.43	451.17	39.51	8.04
Short-Term Investments	267.60	59.84	32.61	0.00
Cash & Short-Term Investments	448.03	511.01	72.11	8.04
Accounts Receivable	2.84	1.06	0.22	0.15
Inventory	0.00	0.00	0.00	0.00
Other Current Assets	23.42	2.10	4.18	1.45
Total Current Assets	474.29	514.17	76.51	9.64
Non-Current Assets
Property, Plant & Equipment (Net)	3.64	3.95	0.33	0.05
Other Non-Current Assets	0.00	8.42	0.00	0.00
Total Non-Current Assets	3.64	12.37	0.33	0.05
Total Assets	477.93	526.54	76.84	9.68
Current Liabilities
Accounts Payable	8.68	0.33	0.16	1.47
Short-Term Debt	1.37	0.00	0.00	15.00
Accrued Liabilities	7.22	8.07	7.24	3.04
Other Current Liabilities	11.77	2.78	1.11	1.23
Total Current Liabilities	22.46	9.97	7.67	21.09
Non-Current Liabilities
Long-Term Debt	1.46	2.50	0.13	0.00
Other Non-Current Liabilities	0.62	0.00	0.00	0.00
Total Non-Current Liabilities	2.08	3.08	0.41	0.24
Total Liabilities	24.54	13.05	8.08	21.33
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.04
Retained Earnings	-235.59	-116.66	-80.65	-53.64
Accumulated Other Comprehensive Income	5.00	2.36	0.35	-0.17
Treasury Stock	0.00	0.00	0.00	0.01
Additional Paid-in Capital	677.41	609.97	129.19	42.06
Minority Interest	6.57	17.82	19.87	0.00
Shares Outstanding	63.08	60.47	38.98	36.93
Total Stockholders' Equity	446.83	513.49	68.77	-11.65
Total Liabilities & Equity	477.93	526.54	76.84	9.68